6-45431915-G-A
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_001024630.4(RUNX2):c.476G>A(p.Gly159Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001024630.4 missense
Scores
Clinical Significance
Conservation
Publications
- cleidocranial dysplasia 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RUNX2 | NM_001024630.4 | c.476G>A | p.Gly159Asp | missense_variant | Exon 4 of 9 | ENST00000647337.2 | NP_001019801.3 | |
| RUNX2 | NM_001369405.1 | c.434G>A | p.Gly145Asp | missense_variant | Exon 2 of 7 | NP_001356334.1 | ||
| RUNX2 | NM_001015051.4 | c.476G>A | p.Gly159Asp | missense_variant | Exon 4 of 8 | NP_001015051.3 | ||
| RUNX2 | NM_001278478.2 | c.434G>A | p.Gly145Asp | missense_variant | Exon 2 of 6 | NP_001265407.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RUNX2 | ENST00000647337.2 | c.476G>A | p.Gly159Asp | missense_variant | Exon 4 of 9 | NM_001024630.4 | ENSP00000495497.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cleidocranial dysostosis Pathogenic:2
Absent from controls (or at extremely low frequency if recessive) in Genome Aggregation Database, Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium.;Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc).;The prevalence of the variant in affected individuals is significantly increased compared to the prevalence in controls.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at